Cryoprecipitate transfusion in trauma patients attenuates hyperfibrinolysis and restores normal clot structure and stability: Results from a laboratory sub-study of the FEISTY trial.

Morrow, G.B., Feller, T., McQuilten, Z., Wake, E., Ariëns, R.A., Winearls, J., Mutch, N.J., Laffan, M.A. and Curry, N., 2022. Cryoprecipitate transfusion in trauma patients attenuates hyperfibrinolysis and restores normal clot structure and stability: Results from a laboratory sub-study of the FEISTY trial. Critical Care, 26(1), pp.1-12.